Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

1.90p
   
  • Change Today:
    -0.14p
  • 52 Week High: 3.42
  • 52 Week Low: 0.85
  • Currency: UK Pounds
  • Shares Issued: 416.44m
  • Volume: 1,925,128
  • Market Cap: £7.91m
  • RiskGrade: 328

Friday broker round-up

By Caoimhe Toman

Date: Friday 23 Mar 2018

LONDON (ShareCast) - (ShareCast News) - Mitie Group: Barclays upgrades to overweight with a target price of 180p.
NMC Health plc: Berenberg reiterates buy with a target price of 4,600p.

Accesso technology group: Berenberg reiterates buy with a target price of 3,000p.

Glaxosmithkline: Deutsche Bank reiterates hold.

Kingfisher: Deutsche Bank reiterates hold with a target price of 315p.

Prudential: Deutsche Bank reiterates buy with a target price of 2,250p.

IQE plc: Citigroup reiterates buy with a target price of 195p.

Ferguson plc: Citigroup reiterates buy with a target price of 6,300p.

Allied Minds plc: Credit Suisse reiterates neutral with a target price of 110p.

Centrica plc: Credit Suisse reiterates outperform with a target price of 175p.

Travis Perkins: Liberum reiterates buy with a target price of 1,525p.

Real Estate Investors: Liberum reiterates buy with a target price of 75p.

Sanne Group: Liberum reiterates buy with a target price of 745p.

ITV: Liberum reiterates buy with a target price of 265p.

Immupharma: Northland Capital Markets reiterates buy with a target price of 181p.

Just Eat: Canaccord downgrades to hold with a target price of 700p.

Lamprell. Canaccord reiterates buy with a target price of 115p.

Wood plc: Canaccord reiterates buy with a target price of 800p.

IGas Energy plc: Canaccord reiterates buy with a target price of 200p.

Indivior: RBC Capital Markets reiterate outperform with a target price of 540p.

Interserve: Berenberg reiterates hold with a target price of 95p.



Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Immupharma Market Data

Currency UK Pounds
Share Price 1.90p
Change Today -0.14p
% Change -6.86 %
52 Week High 3.42
52 Week Low 0.85
Volume 1,925,128
Shares Issued 416.44m
Market Cap £7.91m
RiskGrade 328

Immupharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
62.34% below the market average62.34% below the market average62.34% below the market average62.34% below the market average62.34% below the market average
9.8% below the sector average9.8% below the sector average9.8% below the sector average9.8% below the sector average9.8% below the sector average
Price Trend
44.24% below the market average44.24% below the market average44.24% below the market average44.24% below the market average44.24% below the market average
12.73% above the sector average12.73% above the sector average12.73% above the sector average12.73% above the sector average12.73% above the sector average
Income Not Available
Growth Not Available

Immupharma Dividends

No dividends found

Trades for 03-May-2024

Time Volume / Share Price
16:28 419,759 @ 2.00p
16:29 20,000 @ 2.00p
16:29 47,619 @ 2.01p
16:28 69,550 @ 2.00p
16:28 250,000 @ 2.00p

Immupharma Key Personnel

CEO Timothy Paul McCarthy

Top of Page